» Authors » Neil C Porter

Neil C Porter

Explore the profile of Neil C Porter including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 149
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Morgenstern L, Springer M, Porter N, Kwicklis M, Carrera J, Sozener C, et al.
J Natl Med Assoc . 2023 Aug; 115(5):509-515. PMID: 37634970
Introduction: We studied racial differences in post-stroke outcomes using a prospective, population-based cohort of stroke survivors as part of the Brain Attack Surveillance in Corpus Christi (BASIC) project. Methods: Neurologic...
2.
Porter N, Morgenstern L
JAMA Neurol . 2022 Sep; 79(12):1221-1222. PMID: 36094550
No abstract available.
3.
Brooks J, Porter N, Bisordi K, Miclat C, Greene C
Oral Surg Oral Med Oral Pathol Oral Radiol . 2022 Mar; 133(6):e170-e177. PMID: 35305937
Charcot-Marie-Tooth disease (CMTD) is an uncommon progressive neuromuscular disorder of the peripheral nervous system and primarily leads to distal extremity weakness and sensory deficits. Frequently, affected patients manifest pes cavus,...
4.
Patnaik A, Mininni J, Porter N, Morris N
Case Rep Neurol . 2021 Mar; 13(1):73-77. PMID: 33708097
Acute-onset chronic inflammatory demyelinating polyneuropathy (A-CIDP) is an immune mediated neuropathy characterized by progressive weakness and sensory impairment lasting over 2 months. Guillain-Barré-Strohl syndrome (GBS) is an immune mediated polyneuropathy...
5.
Ortlip T, Drake V, Raghavan P, Papadimitriou J, Porter N, Eisenman D, et al.
Otol Neurotol . 2017 Jun; 38(7):1024-1031. PMID: 28570415
Objective: Inflammatory pseudotumor of the temporal bone is a benign, idiopathic inflammatory process that is locally invasive and a cause of significant morbidity. This study reviews our experience with seven...
6.
Diaz-Abad M, Porter N
Neurol Int . 2014 Jan; 5(4):e21. PMID: 24416485
X-linked spinobulbar muscular atrophy (Kennedy's disease) affects muscles and motor neurons, manifesting as weakness and wasting of bulbar, facial, and proximal limb muscles due to loss of anterior horn cells...
7.
Reed P, Corse A, Porter N, Flanigan K, Bloch R
Exp Neurol . 2007 Apr; 205(2):583-6. PMID: 17451686
To identify proteins expressed abnormally in facioscapulohumeral muscular dystrophy (FSHD), we extracted soluble proteins from deltoid muscle biopsies from unaffected control and FSHD patients and analyzed them using two-dimensional electrophoresis,...
8.
Reed P, Porter N, Strong J, Pumplin D, Corse A, Luther P, et al.
Ann Neurol . 2006 Jan; 59(2):289-97. PMID: 16437580
Objective: We examined the sarcolemma of skeletal muscle from patients with facioscapulohumeral muscular dystrophy (FSHD1A) to learn if, as in other murine and human muscular dystrophies, its organization and relationship...
9.
Porter N, Resneck W, ONeill A, van Rossum D, Stone M, Bloch R
Mol Membr Biol . 2005 Nov; 22(5):421-32. PMID: 16308276
Small ankyrin 1, or sAnk1, is a small, alternatively spliced product of the erythroid ankyrin gene, ANK1, that is expressed in striated muscle and concentrated in the network sarcoplasmic reticulum...
10.
Lovering R, Porter N, Bloch R
Phys Ther . 2005 Nov; 85(12):1372-88. PMID: 16305275
The genetic basis of many muscular disorders, including many of the more common muscular dystrophies, is now known. Clinically, the recent genetic advances have improved diagnostic capabilities, but they have...